Virtual Medicinal Product (VMP)
-
Didanosine 150mg dispersible chewable tablets sugar free
Name Details
Current Name
Didanosine 150mg dispersible chewable tablets sugar free
|
Start Date
10-05-2004
|
End Date
|
Previous Name
Didanosine 150mg dispersible chewable tablets
|
Start Date
10-10-2003
|
End Date
09-05-2004
|
Unit Dose & Form Information
- DF Indicator
- Discrete
- UDFS Indicator
- 1
- UDFS UOM
- tablet
- Unit Dose UOM
- tablet
Summary
- Prescribing Status
- Invalid to prescribe in NHS primary care
- Controlled Drug Category
- No Controlled Drug Status
- Route
- Oral
- Form
- Chewable tablet
- Ontology Form/Route
- tabletchewable.oral, suspension.oral
- Free From
-
Sugar-free
- Non-availability Indicator
- Actual Products not Available
- Name Basis
- rINN - Recommended International Non-proprietary
Codes
- ATC Code
-
J05AF02
BNF |
Current BNF
05030100
|
Start Date
04-04-2022
|
End Date
|
Previous BNF
05030100
|
Start Date
24-02-2005
|
End Date
03-04-2022
|
SNOMED Codes
Code
|
Start Date
|
End Date
|
5005011000001107 |
10-10-2003 |
|
VMP Ingredients
VMP ingredients table
Didanosine |
Based on Ingredient Substance |
|
150 mg |
|
Name
Didanosine
Basis of strength description
Based on Ingredient Substance
BOSS
Strength and UOM (Nmr)
150
Strength and UOM (Dmr)
Parent Products
-
VTM
Didanosine
-
VMP
(Current) Didanosine 150mg dispersible chewabl...
Virtual Medicinal Product Pack (VMPP) Information